drs. A.T. (Tim) Otten

Faculteit Medische Wetenschappen/UMCG

Telefoon:

E-mail:

a.t.otten umcg.nl

ORCID Research Portal

Publicaties

Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease

Otten, A. T., van der Meulen, H. H., Steenhuis, M., Loeff, F. C., Touw, D. J., Kosterink, J. G. W., Frijlink, H. W., Rispens, T., Dijkstra, G., Visschedijk, M. C. & Bourgonje, A. R., mrt.-2024, In: Inflammatory Bowel Diseases. 30, 3, blz. 325–335 11 blz.

Onderzoeksoutput › › peer review

Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance

Geertsema, S., Fagundes, R. R., Otten, A. T., Dijkstra, G., Faber, K. N. & Bourgonje, A. R., apr.-2024, In: Inflammatory Bowel Diseases. 30, 4, blz. 693–694 2 blz.

Onderzoeksoutput: Comment/Letter to the editor › › peer review

The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients

Otten, A. T., Dijkstra, G., Visschedijk, M. C. & Bourgonje, A. R., feb.-2024, In: Inflammatory Bowel Diseases. 30, 2, blz. 318-319 2 blz.

Onderzoeksoutput: Comment/Letter to the editor › › peer review

Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases

Geertsema, S., Otten, A. T., Bouwknegt, D. G., Visschedijk, M. C. & Bourgonje, A. R., mrt.-2023, In: Inflammatory Bowel Diseases. 29, 3, 2 blz., izac265.

Onderzoeksoutput: Comment/Letter to the editor › › peer review

Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process

Ahmed, A. A., Otten, A. T., Gareb, B., Huijmans, J. E., Eissens, A. C., Rehman, A., Dijkstra, G., Kosterink, J. G. W., Frijlink, H. W. & Schellekens, R. C. A., 28-apr.-2023, In: Pharmaceutics. 15, 5, 20 blz., 1354.

Onderzoeksoutput › › peer review

Effects of ileocolonic delivered vitamin B2, B3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn's disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial.

Otten, A. T., Peters, V., Barth, I., Stevens, C. L., Bourgonje, A. R., Frijlink, H. W., Harmsen, H. J. M., Rehman, A., Campmans-Kuijpers, M. J. E. & Dijkstra, G., 14-mrt.-2023, In: BMJ Open. 13, 3, 12 blz., e069654.

Onderzoeksoutput › › peer review

Temporary diverting stoma in therapy-refractory luminal colonic Crohn's disease: an alternative to immediate colorectal resection?

van der Holst, A. M., Otten, A. T., Praag, E. M.M.-V., van Renterghem, A. R. P. K. M., Bourgonje, A. R., van Loo, E. S., Dijkstra, G., Buskens, C. J. & Stassen, L. P. S., jun.-2023, In: Colorectal Disease. 25, 6, blz. 1176-1186 11 blz.

Onderzoeksoutput › › peer review

The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?

Bourgonje, A. R. & Otten, A. T., jul.-2023, In: Clinical Gastroenterology and Hepatology. 21, 7, blz. 1971-1972 4 blz.

Onderzoeksoutput: Comment/Letter to the editor › › peer review

Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD

Otten, A. T., Bourgonje, A. R. & Visschedijk, M. C., feb.-2023, In: The Lancet Gastroenterology and Hepatology. 8, 2, blz. 99-100 2 blz.

Onderzoeksoutput › › peer review

Serological biomarkers of type I, III, and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease

Bourgonje, A. R., Alexdóttir, M. S., Otten, A. T., Loveikyte, R., Bay-Jensen, A.-C., Pehrsson, M., van Dullemen, H. M., Visschedijk, M. C., Festen, E. A. M., Weersma, R. K., Karsdal, M. A., Faber, K. N., Mortensen, J. H. & Dijkstra, G., aug.-2022, In: Alimentary Pharmacology & Therapeutics. 56, 4, blz. 675-693 19 blz.

Onderzoeksoutput › › peer review

Lees meer

Alle (17) publicaties

Bekijk volledig onderzoeksprofiel